Floatz logo

Capsaicin

Peripheral Nerve Injury (PNI)

Astellas Pharma Europe Ltd.Small moleculePhase 4 / ApprovedDormant
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Peripheral Nerve Injury (PNI) cohort.

Asset / SponsorPhaseRating
(±)-TRAMADOL
Astellas Pharma Inc
Phase 4BB
Pregabalin
Astellas Pharma Europe Ltd.
Phase 4BB
Rufinamide
University of Zurich
Phase 2CCC

Same molecule, other indications

Capsaicin is also rated in:

peripheral nervous system disorderDormant
A
Indicative ·
81 / 100
View asset →
diabetic neuropathyDormant
BBB
Indicative ·
78 / 100
View asset →
postherpetic neuralgiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →